• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Centene Completes Acquisition of Wellcare, Creating a Leading Healthcare Enterprise Focused on Government-Sponsored Healthcare Programs

Share:

January 27, 2020

Centene Corporation (NYSE: CNC) (“Centene”) announced today that it has completed its acquisition of WellCare Health Plans, Inc. (“WellCare”).

Centene now provides access to high-quality and affordable healthcare to its more than 24 million members across all 50 states, or 1 in 15 individuals across the nation. The Company will continue to place great emphasis on long-term growth by prioritizing its people, systems and capabilities so that it can better serve its members, providers and government partners.

“We are pleased to have completed this transformational acquisition to create a leading healthcare enterprise committed to helping people live healthier lives through access to high-quality and affordable healthcare solutions,” said Michael F. Neidorff, Centene’s Chairman, President and Chief Executive Officer. “Through the integration planning process, it has become even more apparent that our goals, cultures and values are aligned. Centene is committed to building on our mission to further improve the health of the communities we serve. We look forward to Centene’s next chapter where we will continue to drive growth and create value for shareholders.”

Pursuant to the terms of the merger agreement, as announced on March 27, 2019, WellCare became a wholly owned subsidiary of Centene. Under the terms of the merger agreement, WellCare shareholders received a fixed exchange ratio of 3.38 shares of Centene common stock and $120 in cash for each share of WellCare common stock.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

With the completion of the transaction, the previously announced divestitures of Centene’s Illinois Medicaid and Medicare Advantage plans, WellCare’s Missouri Medicaid and Medicare Advantage plans and WellCare’s Nebraska Medicaid plan have also closed.

WellCare common stock will cease trading as of the close of trading on January 23, 2020.

Source: Prnews Wire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • DBV pulls peanut allergy filing after FDA faults data detailsDBV pulls peanut allergy filing after FDA faults data details
  • Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer PatientsNucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients
  • Novartis taps Cellular Biomedicines to supply Kymriah in ChinaNovartis taps Cellular Biomedicines to supply Kymriah in China
  • Chronus Health Raises $22M for Portable, Rapid Blood Analyzer TechnologyChronus Health Raises $22M for Portable, Rapid Blood Analyzer Technology
  • Ligand Sells Promacta Assets and Royalty for $827 MillionLigand Sells Promacta Assets and Royalty for $827 Million
  • Biolidics Announces Plans to Launch Its COVID-19 Rapid Test Kits in the USBiolidics Announces Plans to Launch Its COVID-19 Rapid Test Kits in the US
  • 23andMe’s Consumer Pharmacogenetics Report No Longer Requires Follow-up Testing for Certain Medications23andMe’s Consumer Pharmacogenetics Report No Longer Requires Follow-up Testing for Certain Medications
  • Canadian Telehealth Startup OnCall Health Lands $6M for Virtual Care PlatformCanadian Telehealth Startup OnCall Health Lands $6M for Virtual Care Platform

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications